Filed: 2/13/2024ACC: 0000935836-24-000133
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $231.23M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$231.23M
Total AUM (reported)
36.53M
Total Shares
Allocation by class
COM$192.23M83.1%
COM NEW$28.35M12.3%
SPONS ADR$10.65M4.6%
Portfolio Concentration
Top 3$134.64M58.2%
4–10$85.82M37.1%
11–25$10.77M4.7%
Top 3 weight
58.2%
Top 10 weight
95.3%
Voting Authority Distribution
Total shares with voting rights: 36.53M
Sole
Full voting authority
36.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
EVOLUS INC
SOLEShares5.33M
TypeSH
Market value$56.16M
24.29%
Sole
5.33M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares9.22M
TypeSH
Market value$41.69M
18.03%
Sole
9.22M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares2.50M
TypeSH
Market value$36.80M
15.92%
Sole
2.50M
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares450K
TypeSH
Market value$33.16M
14.34%
Sole
450K
Shared
0.00
None
0.00
ALIMERA SCIENCES INC
SOLEShares4M
TypeSH
Market value$17.28M
7.47%
Sole
4M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.94M
TypeSH
Market value$13.95M
6.03%
Sole
5.94M
Shared
0.00
None
0.00
GALAPAGOS NV-SPON ADR
SOLEShares261.87K
TypeSH
Market value$10.65M
4.60%
Sole
261.87K
Shared
0.00
None
0.00
XOMA CORP
SOLEShares250K
TypeSH
Market value$4.63M
2.00%
Sole
250K
Shared
0.00
None
0.00
IO BIOTECH INC
SOLEShares1.67M
TypeSH
Market value$3.13M
1.35%
Sole
1.67M
Shared
0.00
None
0.00
SCYNEXIS INC
SOLEShares1.36M
TypeSH
Market value$3.02M
1.31%
Sole
1.36M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares2.77M
TypeSH
Market value$2.75M
1.19%
Sole
2.77M
Shared
0.00
None
0.00
ATEA PHARMACEUTICALS INC
SOLEShares839.51K
TypeSH
Market value$2.56M
1.11%
Sole
839.51K
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares317.78K
TypeSH
Market value$2.10M
0.91%
Sole
317.78K
Shared
0.00
None
0.00
AYTU BIOPHARMA INC
SOLEShares472.47K
TypeSH
Market value$1.34M
0.58%
Sole
472.47K
Shared
0.00
None
0.00
EXAGEN INC
SOLEShares669.68K
TypeSH
Market value$1.33M
0.58%
Sole
669.68K
Shared
0.00
None
0.00
ATYR PHARMA INC
SOLEShares482.26K
TypeSH
Market value$680.0K
0.29%
Sole
482.26K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EVOLUS INCSOLE | COM | 5.33M | SH | $56.16M 24.29% | 5.33M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 9.22M | SH | $41.69M 18.03% | 9.22M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 2.50M | SH | $36.80M 15.92% | 2.50M | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 450K | SH | $33.16M 14.34% | 450K | 0.00 | 0.00 |
ALIMERA SCIENCES INCSOLE | COM NEW | 4M | SH | $17.28M 7.47% | 4M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.94M | SH | $13.95M 6.03% | 5.94M | 0.00 | 0.00 |
GALAPAGOS NV-SPON ADRSOLE | SPONS ADR | 261.87K | SH | $10.65M 4.60% | 261.87K | 0.00 | 0.00 |
XOMA CORPSOLE | COM NEW | 250K | SH | $4.63M 2.00% | 250K | 0.00 | 0.00 |
IO BIOTECH INCSOLE | COM | 1.67M | SH | $3.13M 1.35% | 1.67M | 0.00 | 0.00 |
SCYNEXIS INCSOLE | COM NEW | 1.36M | SH | $3.02M 1.31% | 1.36M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 2.77M | SH | $2.75M 1.19% | 2.77M | 0.00 | 0.00 |
ATEA PHARMACEUTICALS INCSOLE | COM | 839.51K | SH | $2.56M 1.11% | 839.51K | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 317.78K | SH | $2.10M 0.91% | 317.78K | 0.00 | 0.00 |
AYTU BIOPHARMA INCSOLE | COM | 472.47K | SH | $1.34M 0.58% | 472.47K | 0.00 | 0.00 |
EXAGEN INCSOLE | COM | 669.68K | SH | $1.33M 0.58% | 669.68K | 0.00 | 0.00 |
ATYR PHARMA INCSOLE | COM NEW | 482.26K | SH | $680.0K 0.29% | 482.26K | 0.00 | 0.00 |